NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
PTC Therapeutics, Inc. today shared new data being presented from the Phase 3 APHENITY trial and subsequent open-label extension study at the 2025 American College of Medical Genetics and Genomics ...
Malibu and MasterCraft have strong brands and minimal debt but face a steep industry decline. Click here to read my most ...
The S&P/ASX 200 closed 90.6 points higher, up 1.16%. Finally a day for Aussie investors to cheer, and no doubt one that has ...